Statins and liver disease: from concern to 'wonder' drugs?

被引：17

作者：

Bosch, Jaume ^{[1
,2
]}

Forns, Xavier ^{[1
,2
]}

机构：

[1] Univ Barcelona, Hosp Clin IDIBAPS, Liver Unit, E-08036 Barcelona, Spain

[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona 08036, Spain

来源：

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2015年 / 12卷 / 06期

关键词：

HEPATITIS-C;

D O I：

10.1038/nrgastro.2015.78

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

The benefits of statins go beyond decreasing cholesterol levels; in liver disease, statins reduce the risk of progressive liver fibrosis and provide protection during infections and ischaemia-reperfusion injury. New evidence shows that statins improve response to interferon-based anti-HCV therapy, decrease progression to cirrhosis and likelihood of developing hepatocellular carcinoma.

引用

收藏

页码：320 / 321

页数：2

相关论文

共 10 条

[1]

ADDITION OF SIMVASTATIN TO STANDARD TREATMENT IMPROVES SURVIVAL AFTER VARICEAL BLEEDING IN PATIENTS WITH CIRRHOSIS. A DOUBLE-BLIND RANDOMIZED TRIAL (NCT01095185) [J].

Abraldes, J. G. ;

Villanueva, C. ;

Aracil, C. ;

Turnes, J. ;

Hernandez-Guerra, M. ;

Genesca, J. ;

Navascues, C. A. ;

Castellote, J. ;

Calleja, J. L. ;

Albillos, A. ;

Bosch, J. .

JOURNAL OF HEPATOLOGY, 2014, 60 (01) :S525-S525

[2]

Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial [J].

Abraldes, Juan G. ;

Albillos, Agustin ;

Banares, Rafael ;

Turnes, Juan ;

Gonzalez, Rosario ;

Garcia-Pagan, Juan Carlos ;

Bosch, Jaime .

GASTROENTEROLOGY, 2009, 136 (05) :1651-1658

[3]

Butt A A., 2015, Hepatology

[4]

Severe hepatic injury associated with different statins in patients with chronic liver disease: A nationwide population-based cohort study [J].

Chang, Chia-Hsuin ;

Chang, Yi-Cheng ;

Lee, Yen-Chieh ;

Liu, Ying-Chun ;

Chuang, Lee-Ming ;

Lin, Jou-Wei .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) :155-162

[5]

Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction [J].

La Mura, Vincenzo ;

Pasarin, Marcos ;

Meireles, Cintia Z. ;

Miquel, Rosa ;

Rodriguez-Vilarrupla, Aina ;

Hide, Diana ;

Gracia-Sancho, Jorge ;

Carlos Garcia-Pagan, Juan ;

Bosch, Jaime ;

Abraldes, Juan G. .

HEPATOLOGY, 2013, 57 (03) :1172-1181

[6]

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, Multicenter trial [J].

Lewis, James H. ;

Mortensen, Mary Eflen ;

Zweig, Steven ;

Fusco, Mary Jean ;

Medoff, Jeffrey R. ;

Belder, Rene .

HEPATOLOGY, 2007, 46 (05) :1453-1463

[7]

Marrone G., GUT

[8]

Popescu Costin-Ioan, 2014, Biology (Basel), V3, P892, DOI 10.3390/biology3040892

[9]

HCV and Host Lipids: An Intimate Connection [J].

Schaefer, Esperance A. K. ;

Chung, Raymond T. .

SEMINARS IN LIVER DISEASE, 2013, 33 (04) :358-368

[10]

Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: A systematic review and meta-analysis [J].

Zhu, Qianqian ;

Li, Na ;

Han, Qunying ;

Zhang, Pingping ;

Yang, Cuiling ;

Zeng, Xiaoyan ;

Chen, Yanping ;

Lv, Yi ;

Liu, Xi ;

Liu, Zhengwen .

ANTIVIRAL RESEARCH, 2013, 98 (03) :373-379